M-5913-G-A

Position:

Variant summary

Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP6_Very_StrongBS1BS2

In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Mitomap GenBank:
𝑓 0.0089 ( AC: 543 )

Consequence

COX1
missense

Scores

Apogee2
Benign
0.023

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2
Prostate-Cancer-/-hypertension

Conservation

PhyloP100: 2.56
Variant links:
Genes affected
COX1 (HGNC:7419): (mitochondrially encoded cytochrome c oxidase I) Contributes to cytochrome-c oxidase activity. Predicted to be involved in electron transport coupled proton transport and mitochondrial electron transport, cytochrome c to oxygen. Part of mitochondrial respiratory chain complex III and mitochondrial respiratory chain complex IV. [provided by Alliance of Genome Resources, Apr 2022]
TRNY (HGNC:7502): (mitochondrially encoded tRNA tyrosine)

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -16 ACMG points.

BP6
Variant M-5913-G-A is Benign according to our data. Variant chrM-5913-G-A is described in ClinVar as [Benign]. Clinvar id is 692601.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
High frequency in mitomap database: 0.0089
BS2
High AC in GnomadMitoHomoplasmic at 299

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
COX1unassigned_transcript_4799 c.10G>A p.Asp4Asn missense_variant 1/1
TRNYunassigned_transcript_4798 c.-22C>T upstream_gene_variant

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt

Frequencies

GnomAD4 exome
Cov.:
0
We have no GnomAD4 genomes data on this position. Probably position not covered by the project.
Mitomap GenBank
AF:
0.0089
AC:
543
Gnomad homoplasmic
AF:
0.0053
AC:
299
AN:
56419
Gnomad heteroplasmic
AF:
0.000089
AC:
5
AN:
56419
Alfa
AF:
0.00441
Hom.:
36

Mitomap

Prostate-Cancer-/-hypertension

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
Benign, criteria provided, single submitterclinical testingAthena DiagnosticsJul 27, 2020- -
Leigh syndrome Benign:1
Benign, criteria provided, single submitterclinical testingWong Mito Lab, Molecular and Human Genetics, Baylor College of MedicineOct 17, 2019The NC_012920.1:m.5913G>A (YP_003024028.1:p.Asp4Asn) variant in MTCO1 gene is interpretated to be a Benign variant based on the modified ACMG guidelines (unpublished). This variant meets the following evidence codes: BA1 -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
Apogee2
Benign
0.023
Hmtvar
Benign
0.050
AlphaMissense
Benign
0.13
BayesDel_addAF
Benign
-0.58
T
DEOGEN2
Benign
0.0020
T
LIST_S2
Benign
0.65
T
MutationAssessor
Benign
-1.6
N
PROVEAN
Benign
0.20
N
Sift4G
Benign
1.0
T
GERP RS
2.3
Varity_R
0.14

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs201617272; hg19: chrM-5914; API